Wed, January 6, 2021
Tue, January 5, 2021
Mon, January 4, 2021

Stephen Willey Initiated (ABCL) at Strong Buy and Held Target at $59 on, Jan 5th, 2021

Stephen Willey of Stifel, Initiated "AbCellera Biologics Inc." (ABCL) at Strong Buy and Held Target at $59 on, Jan 5th, 2021.

Stephen, nor any peers, have made any analyst calls on ABCL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30